Chemical toll blending has long been a strategic solution for manufacturers looking to optimize production, reduce costs, and meet complex formulation requirements. As industries evolve and customer ...

Bangladesh has expressed its willingness that it may, under the right strategic conditions, consider joining a regional ...

Discover how in silico tools can be used can be used with organ-on-a-chip for the advancement of ADME studies.

OSE Immunotherapeutics SA ( ORPOF) Discusses Strategic Plan With Four Opportunities for Value Creation December 10, 2025 12:00 PM EST ...

GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...

Recent funding round, led by Hudson Bay Capital, fuels expanded capacity and commercialization of formulated intermediates across oil & gas, mining, agriculture and industrial & CPG markets SOLON, ...

OSE Immunotherapeutics Unveils 2026–2028 Strategic Plan With Four Opportunities for Value CreationCompletion of Tedopi’s phase 3 in Non-Small ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these failures stem from unresolved biopharmaceutic ...

Viking Therapeutics advances oral and injectable VK2735 for obesity with strong cash, pipeline depth, and key 2026 catalysts.

The Trump administration released its much-anticipated National Security Strategy this week. CFR convened six of its experts ...

Regulatory pressures in the European Union are rapidly reshaping the landscape for cosmetics and fragrance companies. New ...